The relation of serum gamma-glutamyl transferase levels with coronary lesion complexity and long-term outcome in patients with stable coronary artery disease

Atherosclerosis

Volumn 221, Issue 2, 2012, Pages 596-601

  Aksakal, Enbiya ^a   Tanboga, Ibrahim Halil ^b   Kurt, Mustafa ^b   Kaygin, Mehmet Ali ^b   Kaya, Ahmet ^b   Isik, Turgay ^b   Ekinci, Mehmet ^b   Sevimli, Serdar ^a   Acikel, Mahmut ^a  

^a ATATURK UNIVERSITY   (Turkey)

^b Erzurum Education and Research Hospital   (Turkey)

Author keywords

Serum gamma glutamyl transferase; SYNTAX score

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; DIABETES MELLITUS; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVASCULARIZATION; RISK ASSESSMENT; SMOKING; STABLE ANGINA PECTORIS; SURVIVAL; SYNTAX SCORE; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL REVASCULARIZATION; ODDS RATIO; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TURKEY;

EID: 84858704356     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.01.044     Document Type: Article

References (31)

1. Whitfield J.B. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001, 38:263-355.
2. Paolicchi A., Minotti G., Tonarelli P., et al. Gamma-glutamyl transpeptidase-dependent iron reduction and LDL oxidation-a potential mechanism in atherosclerosis. J Investig Med 1999, 47:151-160.
3. Franzini M., Corti A., Martinelli B., et al. Gamma-glutamyltransferase activity in human atherosclerotic plaques-biochemical similarities with the circulating enzyme. Atherosclerosis 2009, 202:119-127.
4. Strasak A.M., Kelleher C.C., Klenk J., et al. Longitudinal change in serum gamma-glutamyltransferase and cardiovascular disease mortality: a prospective population-based study in 76,113 Austrian adults. Arterioscler Thromb Vasc Biol 2008, 28:1857-1865.
5. Ruttmann E., Brant L.J., Concin H., et al. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 2005, 112:2130-2137.
6. Breitling L.P., Grandi N.C., Hahmann H., et al. Gamma-glutamyltransferase and prognosis in patients with stable coronary heart disease followed over 8 years. Atherosclerosis 2010, 210:649-655.
7. Stojakovic T., Scharnagl H., Trauner M., et al. Serum gamma-glutamyl transferase and mortality in persons undergoing coronary angiography-the Ludwigshafen Risk and Cardiovascular Health Study. Atherosclerosis 2010, 208:564-571.
8. Sianos G., Morel M.A., Kappetein A.P., et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005, 1:219-227.
9. Serruys P.W., Unger F., Sousa J.E., et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001, 344:1117-1124.
10. Capodanno D., Capranzano P., Di Salvo M.E., et al. Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft. JACC Cardiovasc Intervent 2009, 2:731-738.
11. Park D.W., Kim Y.H., Yun S.C., et al. Complexity of atherosclerotic coronary artery disease and long-term outcomes in patients with unprotected left main disease treated with drug-eluting stents or coronary artery bypass grafting. J Am Coll Cardiol 2011, 57:2152-2159.
12. Tanboga I.H., Ekinci M., Isik T., et al. Reproducibility of syntax score: from core lab to real world. J Interv Cardiol 2011, 24:302-306.
13. Madamanchi N.R., Vendrov A., Runge M.S. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2005, 25:29-38.
14. Emdin M., Pompella A., Paolicchi A. Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation 2005, 112:2078-2080.
15. Mason J.E, Starke R.D., Van Kirk J.E. Gamma-glutamyl transferase: a novel cardiovascular risk biomarker. Prev Cardiol 2010, 13:36-41.
16. Acikel M., Sunay S., Koplay M., et al. Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography. Anadolu Kardiyol Derg 2009, 9:273-279.
17. Demircan S., Yazici M., Durna K., et al. The importance of gamma-glutamyltransferase activity in patients with coronary artery disease. Clin Cardiol 2009, 32:220-225.
18. Mohamed R.H., Karam R.A., Abd El-Aziz T.A. The relationship between paraoxonase1-192 polymorphism and activity with coronary artery disease. Clin Biochem 2010, 43:553-558.
19. Yildiz A., Demirbag R., Yilmaz R., et al. The association of serum prolidase activity with the presence and severity of coronary artery disease. Coron Artery Dis 2008, 19:319-325.
20. Duzguncinar O., Yavuz B., Hazirolan T., et al. Plasma myeloperoxidase is related to the severity of coronary artery disease. Acta Cardiol 2008, 63:147-152.
21. Taniguchi H., Momiyama Y., Ohmori R., et al. Associations of plasma C-reactive protein levels with the presence and extent of coronary stenosis in patients with stable coronary artery disease. Atherosclerosis 2005, 178:173-177.
22. Fazlioglu M., Senturk T., Kumbay E., et al. Small arterial elasticity predicts the extent of coronary artery disease: relationship with serum uric acid. Atherosclerosis 2009, 202:200-204.
23. Saijo Y., Utsugi M., Yoshioka E., et al. The relationship of gamma-glutamyltransferase to C-reactive protein and arterial stiffness. Nutr Metab Cardiovasc Dis 2008, 18:211-219.
24. Lee Y.J., Kim J.K., Lee J.H., et al. Association of serum gamma-glutamyltransferase with C-reactive protein levels and white blood cell count in Korean adults. Clin Chem Lab Med 2008, 46:1410-1415.
25. Simao A.N., Dichi J.B., Barbosa D.S., et al. Influence of uric acid and gamma-glutamyltransferase on total antioxidant capacity and oxidative stress in patients with metabolic syndrome. Nutrition 2008, 24:675-681.
26. Onat A., Can G., Ornek E., et al. Serum gamma-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome and coronary disease. Obesity (Silver Spring) 2011.
27. Yoon S.E., Ahn S.G., Kim J.Y., et al. Differential relationship between metabolic syndrome score and severity of coronary atherosclerosis as assessed by angiography in a non-diabetic and diabetic Korean population. J Korean Med Sci 2011, 26:900-905.
28. Yan L.Q., Guo L.J., Zhang F.C., et al. The relationship between kidney function and angiographically-derived SYNTAX score. Can J Cardiol 2011.
29. Cariou B., Bonnevie L., Mayaudon H., et al. Angiographic characteristics of coronary artery disease in diabetic patients compared with matched non-diabetic subjects. Diabetes Nutr Metab 2000, 13:134-141.
30. Ulus T., Yildirir A., Sade L.E., et al. Serum gamma-glutamyl transferase activity: new high-risk criteria in acute coronary syndrome patients?. Coron Artery Dis 2008, 19:489-495.
31. Ulus T., Yildirir A., Demirtas S., et al. Serum gamma-glutamyl transferase activity: a new marker for stent restenosis?. Atherosclerosis 2007, 195:348-353.